SHR-2004 / Jiangsu Hengrui Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SHR-2004 / Jiangsu Hengrui Pharma
NCT06220123: A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Not yet recruiting
2
350
NA
SHR-2004, Enoxaparin Sodium Injection; Rivaroxaban Tablets
Beijing Suncadia Pharmaceuticals Co., Ltd
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
06/25
07/25
NCT05752461: SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Recruiting
2
316
RoW
SHR-2004 injection, Enoxaparin sodium injection
Beijing Suncadia Pharmaceuticals Co., Ltd
Prevention of Venous Thromboembolism After Knee Arthroplasty
06/24
09/24

Download Options